By 2025, the clinical use of marijuana for joint pain is expected to see significant changes. Researchers suggest refined formulations, potentially including advanced phytocannabinoid blends and localized methods of administration, will emerge. While existing studies remains preliminary, future research focusing on particular varieties of arthritis